Bullock-Palmer, Renée P. http://orcid.org/0000-0001-8167-5760
Michos, Erin D.
Gaballa, Dianna
Blankstein, Ron
Article History
Accepted: 26 October 2022
First Online: 28 December 2022
Change Date: 16 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11886-023-01838-1
Compliance with Ethical Standards
:
: Renée P. Bullock-Palmer reports payment or honoraria from the American College of Cardiology Nuclear Cardiology educational product development and delivery of content and the Knowledge to Practice Webinar on the ACC AHA Chest Pain Guidelines. Renée P. Bullock-Palmer also reports being an American Heart Association – Circulation Imaging Editorial Board Member, American Society of Nuclear Cardiology Board Member, Southern NJ American Heart Association Board Member, and International Accreditation Commission CT Board Member. Erin D. Michos reports consulting fees from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Esperion, Novartis, Novo Nordisk, and Pfizer. Ron Blankstein reports Amgen Inc. (Steering Committee Member/Research grant), Novartis Inc. (research); consulting fees from Caristo Inc. and Elucid Inc.; payment or honoraria from Siemens Inc.; and Board of Directors, Society of Cardiovascular Computed Tomography. Dianna Gaballa has no conflicts of interest.
: This article does not contain any studies with human or animal subjects performed by any of the authors.